New Key Statistics Module, Z-Score and F-Score
XSAT:LEVBIO Key Ratios
| Market Cap kr M | 18.26 |
| Enterprise Value kr M | 15.74 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.31 |
| Price/Sales | 0.81 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 23.00 |
| EPS (TTM) kr | -0.11 |
| Beneish M-Score | -3.61 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.45 |
| EV-to-EBITDA | -1.71 |
| PEG | -- |
| Shares Outstanding M | 63.40 |
| Net Margin (%) | -45.35 |
| Operating Margin % | -42.44 |
| Pre-tax Margin (%) | -46.13 |
| Quick Ratio | 0.82 |
| Current Ratio | 1.20 |
| ROA % (ttm) | -62.85 |
| ROE % (ttm) | -124.06 |
| ROIC % (ttm) | -70.05 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.49 |
XSAT:LEVBIO Number of Guru Trades
XSAT:LEVBIO Volume of Guru Trades
Gurus Latest Trades with XSAT:LEVBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSAT:LEVBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers